Indication

Postabortal hemorrhage

Postabortal hemorrhage is a critical obstetrical complication defined as excessive, abnormal uterine bleeding following a spontaneous or induced pregnancy termination. Read more about Postabortal hemorrhage

0 drugs 0 manufacturers

Advertisement

Drugs that treat it

Common Postabortal hemorrhage therapies.

0 drugs

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with Postabortal hemorrhage preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Postabortal hemorrhage.

Postabortal hemorrhage is a critical obstetrical complication defined as excessive, abnormal uterine bleeding following a spontaneous or induced pregnancy termination.

Clinically identified by blood loss commonly exceeding 500 mL, heavy acute bleeding soaking multiple pads per hour, or bleeding accompanied by hemodynamic instability that necessitates urgent interventions like fluid resuscitation or blood transfusion, it directly affects the reproductive tract of female patients.

The underlying pathophysiology most frequently involves uterine atony, retained products of conception, genital tract lacerations, uterine perforation, abnormal placentation, or underlying coagulopathy.

Prompt recognition and intervention are vital to prevent hypovolemic shock, multiorgan hypoperfusion, and maternal mortality.

Personalize your experience

Follow Postabortal hemorrhage and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it